ArticlePloS one2013

PKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytes.

Nikolaus Thuille et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.